Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Spectral AI Inc. (MDAI)

Healthcare Medical Devices
1.60 $
-1.9% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Spectral AI Inc..

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 5 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Basics

Market Cap
0.05$B
Shares Outstanding
32Mio.
Float
86.8%
Beta
1.2

Performance

Perf. 1M
-26.80%
Perf. 3M
13.40%
Perf. 6M
17.40%
YTD Performance (%)
20.40%
52-Week-High Distance
-48.0%
Perf. 1Y
-19.02%
Perf. 3Y
-83.60%
Perf. 5Y
-82.89%

Valuation

P/E
Forward P/E
52.4
PEG
P/B
P/S
2.8
EV/EBITDA
-3.4
Price/FCF

Profitability

Gross Margin
46.0%
EBIT Margin
Net Margin
-82.0%
Return on Equity
-2,308.3%
Return on Assets
-31.5%

Balance Sheet & Safety

Equity Ratio
Debt/Equity
warning zone
Altman Z″
-14.91
weak
Piotroski
1 out of 9

Growth

Sales Growth Last Quarter
-40.50%
EPS Growth Last Quarter
0.00%
Sales Growth (Year)
-33.57%
Forward Sales Growth
24.49%
Forward EPS Growth
-77.40%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage
3
RS Rating
26
EPS Rating
42
weak
Piotroski
1 out of 9
Fundamental Rating
D (27 out of 100)
warning zone
Altman Z″
-14.91

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 1.60 $
Price Target (average) 5.42 $

The price target sits 238.7% above the current price.

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Next Reporting Date

11. Aug 2026 · after the close · Q2 2026
Expected Earnings per Share
-0.14 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Sales Per Quarter ($M)
2024: Q4 · 7.6 $M Q4 2025: Q1 · 6.7 $M Q1 2025: Q2 · 5.1 $M Q2 2025: Q3 · 3.8 $M Q3 2025: Q4 · 3.8 $M Q4 2026: Q1 · 4.0 $M Q1
Earnings Per Share Per Quarter ($)
2024: Q4 · -0.24 $ Q4 2025: Q1 · 0.09 $ Q1 2025: Q2 · -0.25 $ Q2 2025: Q3 · -0.11 $ Q3 2025: Q4 · 0.02 $ Q4 2026: Q1 · -0.11 $ Q1
Net Margin Per Quarter (%)
2024: Q4 · -101.8 % Q4 2025: Q1 · 43.2 % Q1 2025: Q2 · -157.3 % Q2 2025: Q3 · -93.7 % Q3 2025: Q4 · 16.7 % Q4 2026: Q1 · -85.5 % Q1
Operating Cash Flow Per Quarter ($M)
2024: Q4 · 0.5 $M Q4 2025: Q1 · -1.5 $M Q1 2025: Q2 · -3.4 $M Q2 2025: Q3 · -2.5 $M Q3 2025: Q4 · -2.6 $M Q4 2026: Q1 · -3.7 $M Q1
Free Cash Flow Per Quarter ($M)
2024: Q4 · 0.5 $M Q4 2025: Q1 · -1.5 $M Q1 2025: Q2 · -3.4 $M Q2 2025: Q3 · -2.5 $M Q3 2025: Q4 · -2.6 $M Q4 2026: Q1 · -3.7 $M Q1
Sales Growth vs. Year-Ago Quarter (%)
2024: Q4 · 43.8 % Q4 2025: Q1 · 6.0 % Q1 2025: Q2 · -32.3 % Q2 2025: Q3 · -53.6 % Q3 2025: Q4 · -49.4 % Q4 2026: Q1 · -40.5 % Q1
EPS Growth vs. Year-Ago Quarter (%)
2026: Q1 · -217.8 % Q1
Price Change in Quarter (%)
2024: Q4 · 167.0 % Q4 2025: Q1 · -59.4 % Q1 2025: Q2 · 115.7 % Q2 2025: Q3 · -8.1 % Q3 2025: Q4 · -37.7 % Q4 2026: Q1 · 3.5 % Q1

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -0.24 8 43.80 -101.80 1 1
2025: Q1 0.09 7 6.00 43.20 -2 -2
2025: Q2 -0.25 5 -32.30 -157.30 -3 -3
2025: Q3 -0.11 4 -53.60 -93.70 -3 -3
2025: Q4 0.02 4 -49.40 16.70 -3 -3
2026: Q1 -0.11 -217.80 4 -40.50 -85.50 -4 -4
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

About the Company

Spectral AI, Inc., ein KI-Unternehmen, konzentriert sich auf prädiktive medizinische Diagnostik in den USA.

Employees65
HeadquartersDallas, TX
Websitespectral-ai.com
IPO Date6. Apr 2021

Management

Management
Name Title Birth Year
John Michael DiMaio M.D. Founder & Chairman 1956
Vincent Stanley Capone Esq. CEO & Corporate Secretary 1967
Stanley Micek Chief Operating Officer 1962
Allison Kumar Head of Regulatory Affairs & Clinical Trials 1978
Louis Percoco General Manager 1960
Wensheng Fan Co-Founder, Chief Innovation Strategist & Senior Advisor to the CEO 1970
David McGuire Chief Financial Officer 1979

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?